FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing

Lili Zhang, Han Jiang, Lihua Li, Zhen Sun, Yongjiang Qian, Zhongqun Wang · 2024

Read FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing by Lili Zhang, Han Jiang, Lihua Li, Zhen Sun, Yongjiang Qian, Zhongqun Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11606163.txt.

Description

Lili Zhang and five co-authors hunted for a drug target in atherosclerosis, the artery-clogging disease behind most heart harm, in twenty twenty-four. They mined single-cell and bulk gene data from mouse and human arteries. One gene, FSCN1, stood out: it was active mainly in the lining cells of arteries and ran high in diseased human samples.

A clinical cross-check found that high blood levels of the FSCN1 protein went with raised odds of the disease. In cells fed oxidized fat, the protein's levels rose as well. When the team knocked the gene down in lining cells, they watched its effect on an inflammatory cell death and on cell movement. The authors name FSCN1 as a candidate target and marker for the disease, worthy of deeper tests.

Catalog record

CREATORLili Zhang, Han Jiang, Lihua Li, Zhen Sun, Yongjiang Qian, Zhongqun Wang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11606163

Browse the full library · About the Tower of Babel